BAP Pharma PL WP
Biogen receives EMA CHMP recommendation for ALS drug Qalsody
The decision on the marketing authorisation for Biogen Qalsody is expected in Q2 2024.
The decision on the marketing authorisation for Biogen Qalsody is expected in Q2 2024.